Prostatic Neoplasms, Castration-Resistant Not Yet Recruiting Phase 2 Trials for Abiraterone (DB05812)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0001230 (Prostatic Neoplasms, Castration-Resistant) | Not Yet Recruiting | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|